Drugs / YP-P10
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05467293 Comparator | Jun 2022 → Mar 2023 | dry eye syndrome | Yuyu Pharma, Inc. | Completed | No outcome recorded |
Press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2023-04-17 | Yuyu Pharma, Inc. | 유유제약, 글로벌 안과학회에서 YP-P10 신규 연구결과 발표 예정 yuyu.co.kr ↗ |
| 2022-07-21 | Yuyu Pharma, Inc. | 유유제약, 안구건조증 치료제 YP-P10 美임상 2상 순항 yuyu.co.kr ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YP-P10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05467293 ↗ |